• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

设计高生物利用度控释尼莫地平片的两步策略:推拉渗透泵与微粉化/固体分散技术相结合。

A two-step strategy to design high bioavailable controlled-release nimodipine tablets: the push-pull osmotic pump in combination with the micronization/solid dispersion techniques.

作者信息

Liu Xiaohong, Wang Shang, Chai Liqing, Zhang Dong, Sun Yinghua, Xu Lu, Sun Jin

机构信息

Department of Biopharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, No. 103, Wenhua Road, Shenyang 110016, China.

Department of Biopharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, No. 103, Wenhua Road, Shenyang 110016, China; Shanxi Provincial People's Hospital, No. 29, Shuangta Street, Taiyuan, China.

出版信息

Int J Pharm. 2014 Jan 30;461(1-2):529-39. doi: 10.1016/j.ijpharm.2013.12.023. Epub 2013 Dec 25.

DOI:10.1016/j.ijpharm.2013.12.023
PMID:24374219
Abstract

In order to decrease the fluctuation of blood concentration and to increase the oral bioavailability of nimodipine (NMD), a two-step strategy including the push-pull osmotic pump (PPOP) method in combination with micronization and solid dispersion techniques, was used to prepare the controlled-release high-bioavailability solid dosages. The optimization of formulation and process was conducted by comparing effects of different solubilization methods on release behavior of NMD. The in vitro dissolution studies indicated that both the two strategies were able to deliver NMD in the predetermined zero-order manner from 2 to 12h, regardless of effects of release media and agitation rates. Although the Cmax values of two PPOP tablets were lower than that of the reference formulation, both the Tmax values were prolonged, demonstrating the prominent controlled release performance. In comparison with the commercial reference tables, the relative bioavailability of the two formulations was 67.0% and 121.1%, respectively, indicating the solid dispersion technique was more efficient than the micronization technique in terms of solubilization capability and absorption enhancement. In summary, the two-step strategy, combining the push-pull osmotic pump method with the solid dispersion technique, is a very effective method to prepare high bioavailable controlled-release formulations of the poorly soluble drugs, i.e. NMD, taking into account the therapeutical efficiency and safety.

摘要

为降低血药浓度波动并提高尼莫地平(NMD)的口服生物利用度,采用了两步策略,即将推拉渗透泵(PPOP)方法与微粉化和固体分散技术相结合,制备控释高生物利用度固体剂型。通过比较不同增溶方法对NMD释放行为的影响来进行制剂和工艺的优化。体外溶出度研究表明,两种策略均能在2至12小时内以预定的零级方式释放NMD,且不受释放介质和搅拌速率的影响。虽然两种PPOP片剂的Cmax值均低于参比制剂,但Tmax值均延长,显示出显著的控释性能。与市售参比片剂相比,两种制剂的相对生物利用度分别为67.0%和121.1%,表明在增溶能力和吸收增强方面,固体分散技术比微粉化技术更有效。总之,考虑到治疗效果和安全性,将推拉渗透泵方法与固体分散技术相结合的两步策略是制备难溶性药物(即NMD)高生物利用度控释制剂的非常有效的方法。

相似文献

1
A two-step strategy to design high bioavailable controlled-release nimodipine tablets: the push-pull osmotic pump in combination with the micronization/solid dispersion techniques.设计高生物利用度控释尼莫地平片的两步策略:推拉渗透泵与微粉化/固体分散技术相结合。
Int J Pharm. 2014 Jan 30;461(1-2):529-39. doi: 10.1016/j.ijpharm.2013.12.023. Epub 2013 Dec 25.
2
Nimodipine semi-solid capsules containing solid dispersion for improving dissolution.含固体分散体的尼莫地平半固体胶囊,用于改善溶出度。
Int J Pharm. 2008 Jul 9;359(1-2):144-9. doi: 10.1016/j.ijpharm.2008.03.040. Epub 2008 Apr 7.
3
Development of novel core-shell dual-mesoporous silica nanoparticles for the production of high bioavailable controlled-release fenofibrate tablets.新型核壳双介孔二氧化硅纳米颗粒用于制备高生物利用度的非诺贝特控释片的研发。
Drug Dev Ind Pharm. 2016;42(2):199-208. doi: 10.3109/03639045.2015.1039018. Epub 2015 Jun 26.
4
Preparation of a push-pull osmotic pump of felodipine solubilized by mesoporous silica nanoparticles with a core-shell structure.具有核壳结构的介孔二氧化硅纳米粒子增溶的非洛地平推挽式渗透泵的制备。
Int J Pharm. 2014 Nov 20;475(1-2):298-305. doi: 10.1016/j.ijpharm.2014.08.033. Epub 2014 Aug 20.
5
Application of hot-melt extrusion technology for designing an elementary osmotic pump system combined with solid dispersion for a novel poorly water-soluble antidepressant.热熔挤出技术在设计一种结合固体分散体的初级渗透泵系统用于一种新型难溶性抗抑郁药物中的应用。
Pharm Dev Technol. 2016 Dec;21(8):1006-1014. doi: 10.3109/10837450.2015.1089896. Epub 2015 Oct 8.
6
[Design push-pull osmotic pump tablets of famotidine based on an expert system for the formulation design of osmotic pump of poor water-soluble drug].[基于难溶性药物渗透泵制剂设计专家系统设计法莫替丁推拉式渗透泵片]
Yao Xue Xue Bao. 2011 Jan;46(1):109-14.
7
A novel osmotic pump-based controlled delivery system consisting of pH-modulated solid dispersion for poorly soluble drug flurbiprofen: in vitro and in vivo evaluation.一种基于渗透泵的新型控释系统,由用于难溶性药物氟比洛芬的pH调节固体分散体组成:体外和体内评价。
Drug Dev Ind Pharm. 2015;41(12):2089-99. doi: 10.3109/03639045.2015.1078348. Epub 2015 Aug 24.
8
Controlled release of ziprasidone solid dispersion systems from osmotic pump tablets with enhanced bioavailability in the fasted state.齐拉西酮固体分散体系统从渗透泵片中的控释及其在禁食状态下提高的生物利用度。
Drug Dev Ind Pharm. 2015;41(8):1353-62. doi: 10.3109/03639045.2014.950273. Epub 2014 Aug 20.
9
A novel asymmetric membrane osmotic pump capsule with in situ formed delivery orifices for controlled release of gliclazide solid dispersion system.一种新型非对称膜渗透泵胶囊,具有原位形成的释药孔,用于格列齐特固体分散体系统的控释。
Int J Pharm. 2016 Jun 15;506(1-2):340-50. doi: 10.1016/j.ijpharm.2016.04.061. Epub 2016 Apr 27.
10
Controlled release of glaucocalyxin - a self-nanoemulsifying system from osmotic pump tablets with enhanced bioavailability.青兰苷的控释——一种具有增强生物利用度的渗透泵片自纳米乳化系统。
Pharm Dev Technol. 2017 Mar;22(2):148-155. doi: 10.3109/10837450.2015.1089901. Epub 2015 Sep 23.

引用本文的文献

1
RSM and AI based machine learning for quality by design development of rivaroxaban push-pull osmotic tablets and its PBPK modeling.基于响应面法(RSM)和人工智能的机器学习用于利伐沙班推拉渗透泵片的质量源于设计开发及其生理药代动力学(PBPK)建模
Sci Rep. 2025 Mar 7;15(1):7922. doi: 10.1038/s41598-025-91601-z.
2
Three-Dimensional (3D)-Printed Zero-Order Released Platform: a Novel Method of Personalized Dosage Form Design and Manufacturing.三维(3D)打印零级释放平台:一种个性化剂型设计和制造的新方法。
AAPS PharmSciTech. 2021 Jan 6;22(1):37. doi: 10.1208/s12249-020-01886-8.
3
Advances in drug delivery systems: Work in progress still needed?
药物递送系统的进展:仍需要进行中的工作吗?
Int J Pharm X. 2020 Jun 12;2:100050. doi: 10.1016/j.ijpx.2020.100050. eCollection 2020 Dec.
4
Double-layered osmotic pump controlled release tablets of actarit: and evaluation.阿扎司琼双层渗透泵控释片及其评价
Asian J Pharm Sci. 2019 May;14(3):340-348. doi: 10.1016/j.ajps.2018.05.009. Epub 2018 Aug 19.
5
Preparation and characterization of nimodipine-loaded nanostructured lipid systems for enhanced solubility and bioavailability.载尼莫地平纳米结构脂质系统的制备及特性研究,以提高其溶解度和生物利用度。
Int J Nanomedicine. 2018 Dec 21;14:119-133. doi: 10.2147/IJN.S186899. eCollection 2019.
6
Nimodipine Ophthalmic Formulations for Management of Glaucoma.用于治疗青光眼的尼莫地平眼用制剂。
Pharm Res. 2017 Apr;34(4):809-824. doi: 10.1007/s11095-017-2110-x. Epub 2017 Feb 2.
7
Development of an oral push-pull osmotic pump of fenofibrate-loaded mesoporous silica nanoparticles.载非诺贝特介孔二氧化硅纳米粒口服推拉渗透泵的研制。
Int J Nanomedicine. 2015 Mar 3;10:1691-701. doi: 10.2147/IJN.S76755. eCollection 2015.